Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells. [electronic resource]
Producer: 20090416Description: 395-401 p. digitalISSN:- 0250-7005
- Animals
- Antineoplastic Combined Chemotherapy Protocols -- pharmacology
- Apoptosis -- drug effects
- Bufonidae
- Cell Cycle -- drug effects
- Cell Growth Processes -- drug effects
- Colonic Neoplasms -- drug therapy
- Curcumin -- pharmacology
- DNA, Neoplasm -- metabolism
- Drug Synergism
- HCT116 Cells
- Humans
- NF-kappa B -- metabolism
- Oncogene Protein v-akt -- metabolism
- Phosphorylation -- drug effects
- Skin -- chemistry
- Tissue Extracts -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.